Closing -TB GAPs - for People Living with HIV: TB Guidance for Adaptable Patient-Centered Service

Launched by BAYLOR COLLEGE OF MEDICINE · Apr 21, 2022

Keywords

ClinConnect Summary

This clinical trial, called Closing -TB GAPs, is focused on improving the way tuberculosis (TB) is detected and treated in people living with HIV, especially children and adolescents. TB is a serious disease that can be deadly, particularly for those with HIV. The study aims to find better ways to screen for TB, ensuring that the right people get tested, and to identify effective strategies to help patients start and complete preventive treatment for TB. By gathering this information, the researchers hope to improve overall health outcomes for people living with both HIV and TB.

To participate in this trial, individuals must be HIV positive or, in the case of infants, presumptively positive while awaiting confirmatory testing. Participants should not currently be treated for TB. Those who enroll can expect to be part of a project that will explore new methods for TB screening and treatment, contributing to important advancements in healthcare for those affected by these conditions. The study is supported by the CDC and is currently recruiting participants.

Gender

ALL

Eligibility criteria

• OBJECTIVES 1 and 2:
• Inclusion Criteria:
• • HIV positive or HIV exposed and presumptively positive while awaiting confirmatory testing in infants
• Exclusion Criteria:
• • do not provide informed consent or assent as appropriate or are currently being treated for TB
• OBJECTIVE 3:
• Inclusion Criteria:
• • negative TB symptom screen OR for whom TB disease has been ruled out in accordance with WHO Guidelines in adults and according to consensus definitions for child TB
• Exclusion Criteria:
• • do not provide informed consent or assent as appropriate or are currently being treated for TB